BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29189741)

  • 1. The Antitumor Constituents from Hedyotis Diffusa Willd.
    Wang C; Zhou X; Wang Y; Wei D; Deng C; Xu X; Xin P; Sun S
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29189741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iridoids and sfingolipids from Hedyotis diffusa.
    Wang C; Xin P; Wang Y; Zhou X; Wei D; Deng C; Sun S
    Fitoterapia; 2018 Jan; 124():152-159. PubMed ID: 29122633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new iridoid glucosides from Hedyotis diffusa.
    Zhang Y; Chen Y; Fan C; Ye W; Luo J
    Fitoterapia; 2010 Sep; 81(6):515-7. PubMed ID: 20080156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
    Han X; Zhang X; Wang Q; Wang L; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new iridoid glycosides from
    Wu J; Ye ZJ; Yu LJ; Chen XQ
    J Asian Nat Prod Res; 2023 Jan; 25(1):27-35. PubMed ID: 35503565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice.
    Ye JH; Liu MH; Zhang XL; He JY
    Int J Mol Sci; 2015 Nov; 16(11):27252-69. PubMed ID: 26580602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective enrichment of iridoid glucosides in Hedyotis diffusa Willd. by tandem solid phase extraction].
    Zhang F; Guo Z; Zhang F; Xue X; Liang X
    Se Pu; 2009 Jul; 27(4):436-41. PubMed ID: 19938499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seventeen undescribed iridoid derivatives with anti-inflammatory effects from Hedyotis diffusa and their structure-activity relationships.
    Qin LF; Gao HH; Zhang X; Yuan X; Feng ZM; Zhang PC; Jiang JS; Yang YN
    Phytochemistry; 2024 Jan; 217():113904. PubMed ID: 37926152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
    Bai Y; Chen R; Sun J; Guo Y
    Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
    Xu GH; Kim YH; Chi SW; Choo SJ; Ryoo IJ; Ahn JS; Yoo ID
    Bioorg Med Chem Lett; 2010 Jan; 20(2):513-5. PubMed ID: 20004577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
    PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic ion filtering targeted screening and isolation of anti-inflammatory iridoid glycosides from Hedyotis diffusa.
    Shi F; Tong C; He C; Shi S; Cao Y; Wei Q
    J Sep Sci; 2021 Jul; 44(13):2612-2619. PubMed ID: 33884739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics.
    Chen R; He J; Tong X; Tang L; Liu M
    Molecules; 2016 May; 21(6):. PubMed ID: 27248992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Multi-Target Pharmacological Mechanism of
    Song Y; Wang H; Pan Y; Liu T
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective 2D-RPLC/RPLC enrichment and separation of micro-components from Hedyotis diffusa Willd. and characterization by using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li C; Zhao Y; Guo Z; Zhang X; Xue X; Liang X
    J Pharm Biomed Anal; 2014 Oct; 99():35-44. PubMed ID: 25061712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, purification, structural characteristics, pharmacological activities, and combined action of Hedyotis diffusa polysaccharides: A review.
    Zhang R; Ma C; Wei Y; Wang X; Jia J; Li J; Li K; Cao G; Yang P
    Int J Biol Macromol; 2021 Jul; 183():119-131. PubMed ID: 33905802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol extract of Hedyotis diffusa willd upregulates G0/G1 phase arrest and induces apoptosis in human leukemia cells by modulating caspase cascade signaling and altering associated genes expression was assayed by cDNA microarray.
    Kuo YJ; Yang JS; Lu CC; Chiang SY; Lin JG; Chung JG
    Environ Toxicol; 2015 Sep; 30(10):1162-77. PubMed ID: 24677778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive two-dimensional liquid chromatography tandem diode array detector (DAD) and accurate mass QTOF-MS for the analysis of flavonoids and iridoid glycosides in Hedyotis diffusa.
    Li D; Schmitz OJ
    Anal Bioanal Chem; 2015 Jan; 407(1):231-40. PubMed ID: 25171829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells.
    Lin J; Chen Y; Wei L; Chen X; Xu W; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2010 Nov; 37(5):1331-8. PubMed ID: 20878081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
    Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
    J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.